By Fisher, JD, CHC, CCEP
Radiation Therapy Referral Kickback Arrangements with Investors
Overview
A national operator of radiation therapy centers agreed to resolve allegations that it caused the submission of false claims by entering into investment-related arrangements that allegedly violated the Anti-Kickback Statute. The resolution included an $11.5 million payment and a five-year Corporate Integrity Agreement with the Office of Inspector General, reflecting the government’s continued scrutiny of financial relationships that may influence health care referrals.
Key Allegations
- The government alleged that the operator structured payments to investors who were selected, at least in part, because of their ability to refer patients to affiliated radiation therapy centers.
- The challenged structure reportedly used leasing companies as investment vehicles through which referring physicians could hold interests and receive returns.
- According to the government’s theory, those investment returns constituted remuneration intended to induce or reward referrals, thereby implicating the Anti-Kickback Statute.
- Because claims resulting from Anti-Kickback Statute violations may be treated as false or fraudulent, the alleged conduct also supported liability under the False Claims Act.
- The whistleblower who initiated the matter may receive up to $1.725 million, underscoring the role of qui tam relators in surfacing referral-related enforcement issues.
Compliance Takeaway
The matter highlights the enforcement risk associated with investment opportunities offered to referral sources. Even where an investment vehicle has a facially legitimate business purpose, regulators may examine whether the opportunity was marketed to, structured for, or disproportionately made available to physicians or other parties with referral capacity. The key legal concern is whether the economic return functions as disguised remuneration for referrals rather than a bona fide return on investment. Organizations should therefore evaluate investor selection criteria, return methodology, ownership terms, and communications with referral sources to determine whether the arrangement could be characterized as conferring value in exchange for federally reimbursable business.
Practical Compliance Considerations
Maintain contemporaneous compliance documentation. Organizations should preserve valuation support, board approvals, legal analyses, and conflict-of-interest reviews demonstrating that the arrangement was designed and operated for legitimate business purposes.
Assess investor eligibility criteria. Organizations should document objective, commercially reasonable criteria for selecting investors and avoid criteria that correlate with referral volume, referral potential, or influence over federally reimbursable business.
Evaluate whether returns reflect fair market value. Investment returns should be supported by legitimate business economics and should not vary based on the volume or value of referrals or other business generated by the investor.
Review communications with referral sources. Marketing materials, emails, pitch decks, and internal communications should be assessed for language suggesting that investment opportunities are being offered to secure, reward, or retain referrals.
Analyze structure, not just form. The use of intermediary entities, leasing companies, or other layered arrangements will not insulate a transaction if the economic substance suggests remuneration for referrals.
